Wolverine Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-27,121
| Closed | -$2.55M | – | 1791 |
|
|
2025
Q3 | $2.28M | Sell |
27,121
-14,068
| -34% | -$1.16M | 0.02% | 528 |
|
|
2025
Q2 | $3.26M | Buy |
41,189
+21,314
| +107% | +$1.69M | 0.03% | 432 |
|
|
2025
Q1 | $1.78M | Buy |
19,875
+12,198
| +159% | +$1.14M | 0.02% | 542 |
|
|
2024
Q4 | $764K | Sell |
7,677
-8,742
| -53% | -$901K | 0.01% | 768 |
|
|
2024
Q3 | $1.86M | Buy |
16,419
+7,303
| +80% | +$868K | 0.02% | 525 |
|
|
2024
Q2 | $1.13M | Buy |
+9,116
| New | +$1.17M | 0.01% | 640 |
|
|
2024
Q1 | – | Sell |
-5,532
| Closed | -$682K | – | 1814 |
|
|
2023
Q4 | $603K | Sell |
5,532
-37,932
| -87% | -$3.94M | 0.01% | 841 |
|
|
2023
Q3 | $4.47M | Buy |
43,464
+38,770
| +826% | +$4.18M | 0.05% | 341 |
|
|
2023
Q2 | $542K | Sell |
4,694
-297,534
| -98% | -$33.8M | 0.01% | 818 |
|
|
2023
Q1 | $32.2M | Buy |
302,228
+269,577
| +826% | +$29.1M | 0.38% | 66 |
|
|
2022
Q4 | $3.62M | Buy |
32,651
+11,176
| +52% | +$1.14M | 0.04% | 419 |
|
|
2022
Q3 | $1.85M | Buy |
+21,475
| New | +$1.92M | 0.02% | 595 |
|
|
2021
Q3 | – | Sell |
-6,879
| Closed | -$534K | – | 2214 |
|
|
2021
Q2 | $534K | Buy |
+6,879
| New | +$512K | ﹤0.01% | 874 |
|
|
2020
Q1 | – | Sell |
-1,154
| Closed | -$100K | – | 1599 |
|
|
2019
Q4 | $100K | Sell |
1,154
-2,598
| -69% | -$213K | ﹤0.01% | 1080 |
|
|
2019
Q3 | $301K | Sell |
3,752
-8,662
| -70% | -$694K | ﹤0.01% | 895 |
|
|
2019
Q2 | $993K | Buy |
+12,414
| New | +$951K | 0.01% | 653 |
|
|
2019
Q1 | – | Sell |
-194
| Closed | -$14K | – | 1597 |
|
|
2018
Q4 | $14K | Sell |
194
-5,659
| -97% | -$399K | ﹤0.01% | 1514 |
|
|
2018
Q3 | $396K | Sell |
5,853
-1,587
| -21% | -$101K | ﹤0.01% | 1072 |
|
|
2018
Q2 | $430K | Sell |
7,440
-19,290
| -72% | -$1.09M | 0.01% | 972 |
|
|
2018
Q1 | $1.39M | Sell |
26,730
-46,985
| -64% | -$2.54M | 0.02% | 659 |
|
|
2017
Q4 | $3.96M | Sell |
73,715
-35,442
| -32% | -$1.96M | 0.04% | 331 |
|
|
2017
Q3 | $6.67M | Sell |
109,157
-72,858
| -40% | -$4.42M | 0.07% | 205 |
|
|
2017
Q2 | $11.1M | Buy |
182,015
+34,392
| +23% | +$2.09M | 0.14% | 136 |
|
|
2017
Q1 | $8.95M | Sell |
147,623
-66,209
| -31% | -$4.02M | 0.14% | 141 |
|
|
2016
Q4 | $12M | Buy |
+213,832
| New | +$12.5M | 0.16% | 131 |
|
|
2016
Q2 | – | Sell |
-47,160
| Closed | -$2.51M | – | 1284 |
|
|
2016
Q1 | $2.38M | Sell |
47,160
-570
| -1% | -$27.9K | 0.07% | 260 |
|
|
2015
Q4 | $2.4M | Sell |
47,730
-12,367
| -21% | -$624K | 0.05% | 303 |
|
|
2015
Q3 | $2.83M | Sell |
60,097
-6,183
| -9% | -$328K | 0.07% | 264 |
|
|
2015
Q2 | $3.6M | Sell |
66,280
-11,947
| -15% | -$670K | 0.08% | 212 |
|
|
2015
Q1 | $4.29M | Buy |
78,227
+2,686
| +4% | +$152K | 0.09% | 181 |
|
|
2014
Q4 | $4.09M | Buy |
75,541
+42,674
| +130% | +$2.38M | 0.08% | 186 |
|
|
2014
Q3 | $1.86M | Sell |
32,867
-35,203
| -52% | -$1.98M | 0.04% | 323 |
|
|
2014
Q2 | $3.76M | Buy |
68,070
+23,090
| +51% | +$1.26M | 0.08% | 185 |
|
|
2014
Q1 | $2.44M | Sell |
44,980
-5,974
| -12% | -$309K | 0.05% | 250 |
|
|
2013
Q4 | $2.43M | Buy |
50,954
+21,589
| +74% | +$987K | 0.05% | 290 |
|
|
2013
Q3 | $1.33M | Sell |
29,365
-19,912
| -40% | -$909K | 0.03% | 449 |
|
|
2013
Q2 | $2.18M | Buy |
+49,277
| New | +$2.2M | 0.06% | 282 |
|
Other funds holding MRK
Wolverine Asset Management's MRK Position: Q4 2025 in Review
Wolverine Asset Management sold out of Merck (MRK) in Q4 2025, closing a stake of 27,121 shares — an estimated $2.55M sold.
Wolverine Asset Management first reported a position in MRK in Q2 2013 and held it in 37 quarters. The position peaked at $32.2M in Q1 2023. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- Wolverine Asset Management reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
- Wolverine Asset Management sold 27,121 Merck shares in Q4 2025, an estimated $2.55M.
- Wolverine Asset Management first reported a position in Merck in Q2 2013 and held it in 37 quarters.
- Wolverine Asset Management's Merck position peaked at $32.2M in Q1 2023.
- 3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on Wolverine Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.